Lupin Seeks To Preempt Claim Over Ramipril Patent
Mumbai, India-based Lupin and its American marketing affiliate, Lupin Pharmaceuticals Inc., filed the suit for declaratory judgment Thursday in the U.S. District Court for the Eastern District of Virginia. The complaint names King and Germany's Sanofi-Aventis Deutschland GmbH, which owns the patent-in-suit.
Aventis licenses U.S. Patent Number...
To view the full article, register now.